Skip to content

Drug interactions

Thiotepa + Tofacitinib

Severity: Major

Thiotepa and Tofacitinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Thiotepa causes marked myelosuppression and immunosuppression, so concurrent tofacitinib increases the risk of serious infection and cytopenias.

What this interaction means in plain words

Thiotepa and Tofacitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Thiotepa belongs to Oncology; Tofacitinib belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Additive immunosuppression and myelosuppression from JAK inhibition and alkylating chemotherapy.

What to do

Avoid the combination and hold tofacitinib around thiotepa treatment. If unavoidable, monitor blood counts and infection closely.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Thiotepa and Tofacitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Thiotepa with Tofacitinib?

MediHelp rates the interaction as major. Thiotepa and Tofacitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Thiotepa causes marked myelosuppression and immunosuppression, so concurrent tofacitinib increases the risk of serious infection and cytopenias.

How serious is the interaction between Thiotepa and Tofacitinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination and hold tofacitinib around thiotepa treatment. If unavoidable, monitor blood counts and infection closely.

What other medicines interact with Tofacitinib?

MediHelp also lists interactions of Tofacitinib with, for example, Baricitinib, Cladribine, Upadacitinib. The full list is on the Tofacitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in